COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
3.135
+0.145 (4.85%)
Apr 17, 2025, 4:00 PM EDT - Market closed
COMPASS Pathways Employees
COMPASS Pathways had 166 employees as of December 31, 2024. The number of employees decreased by 20 or -10.75% compared to the previous year.
Employees
166
Change (1Y)
-20
Growth (1Y)
-10.75%
Revenue / Employee
n/a
Profits / Employee
-$934,470
Market Cap
290.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 166 | -20 | -10.75% |
| Dec 31, 2023 | 186 | 5 | 2.76% |
| Dec 31, 2022 | 181 | 65 | 56.03% |
| Dec 31, 2021 | 116 | 54 | 87.10% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
CMPS News
- 21 days ago - This Is a Test From GlobeNewswire - GlobeNewsWire
- 24 days ago - Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression - Business Wire
- 4 weeks ago - Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression - Business Wire
- 5 weeks ago - Compass Pathways to Participate in Stifel Virtual CNS Forum - Business Wire
- 7 weeks ago - Compass Pathways: Betting On The Future Of Psilocybin Therapy - Seeking Alpha
- 7 weeks ago - Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says - Benzinga
- 7 weeks ago - COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights - Business Wire